Epilepsy Research
Volume 30, Issue 1 , Pages 63-68, March 1998

Inhibition of pentylenetetrazol-induced seizures in rats by prostaglandin D2

Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, University of Ankara, 06100 Sihhiye, Ankara, Turkey

Received 13 August 1997; received in revised form 27 October 1997; accepted 28 October 1997.

Abstract 

This study was undertaken to evaluate the role of brain PGD2 activity during PTZ induced seizures in rats. Potentiation of endogenous PGD2 activity caused an anti-convulsant effect. Thus, after PGD2 injection (5 μg/icv) the latency of generalized tonic clonic convulsions was prolonged. ZK 118.182, a stable analogue of PGD2, dose-dependently inhibited the incidence and the intensity of seizures when injected at doses of 1–100 ng/icv. But on the other hand, inhibition of PGD2 activity either by a D-type PG receptor antagonist (AH 6809; 50 ng/icv) or by a PGD synthase inhibitor (sodium selenite; 0.2 μg/icv) produced a proconvulsant effect by increasing the incidence and the intensity of the seizures. These findings indicate that endogenous PGD2 activity in the brain may have a specific inhibitory role for the initiation and propagation of PTZ induced seizures in rats.

Keywords:  PGD2, PTZ seizure, ZK 118.182, AH 6809, Sodium selenite, Rat

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-1211(97)00092-2

Epilepsy Research
Volume 30, Issue 1 , Pages 63-68, March 1998